Stargardt disease (STGD1) is the most common inherited retinal dystrophy and ABCA4 c.546--10 T>C is the most commonly reported splice mutation. Here, we generated and characterized two induced pluripotent stem cell (iPSC) lines from a STGD1 patient with compound heterozygous mutations in ABCA4 (c.[5461-10 T > C;5603A > T];[4163 T > C;455G > A]). Episomal vectors containing OCT4, SOX2, KLF4, L-MYC, LIN28 and mp53DD were employed to conduct the reprogramming of patient-derived fibroblasts. Both lines had a normal karyotype, displayed iPSC morphology, expressed pluripotency markers and showed trilineage differentiation potential. These lines can provide a powerful platform for further investigating the pathophysiological consequences of mutations in ABCA4.
Pubmed ID: 34198153 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Software that estimates copy number and annotates regions with copy number variants(CNV).
View all literature mentionsVisualize and analyze data generated by all of Illumina''s platforms.
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis recombinant polyclonal targets KLF4
View all literature mentionsThis polyclonal targets SOX2
View all literature mentionsThis polyclonal targets NANOG
View all literature mentionsThis polyclonal targets Oct4
View all literature mentions